Works matching IS 09024441 AND DT 2010 AND VI 85 AND IP 3


Results: 15
    1
    2
    3

    Reasons for treating secondary AML as de novo AML.

    Published in:
    European Journal of Haematology, 2010, v. 85, n. 3, p. 217, doi. 10.1111/j.1600-0609.2010.01464.x
    By:
    • Granfeldt^Østgård, Lene Sofie;
    • Kjeldsen, Eigil;
    • Holm, Mette Skov;
    • Brown, Peter De Nully;
    • Pedersen, Bjarne Bach;
    • Bendix, Knud;
    • Johansen, Preben;
    • Kristensen, Jørgen Schøler;
    • Nørgaard, Jan Maxwell
    Publication type:
    Article
    4
    5
    6
    7
    8

    Changes in RPS14 expression levels during lenalidomide treatment in Low- and Intermediate-1-risk myelodysplastic syndromes with chromosome 5q deletion.

    Published in:
    European Journal of Haematology, 2010, v. 85, n. 3, p. 231, doi. 10.1111/j.1600-0609.2010.01473.x
    By:
    • Oliva, Esther N.;
    • Cuzzola, Maria;
    • Nobile, Francesco;
    • Ronco, Francesca;
    • D'Errigo, Maria Grazia;
    • Lagan, Carmelo;
    • Morabito, Fortunato;
    • Galimberti, Sara;
    • Cortelezzi, Agostino;
    • Aloe Spiriti, Maria A.;
    • Specchia, Giorgina;
    • Poloni, Antonella;
    • Breccia, Massimo;
    • Ghio, Riccardo;
    • Finelli, Carlo;
    • Iacopino, Pasquale;
    • Alimena, Giuliana;
    • Latagliata, Roberto
    Publication type:
    Article
    9
    10
    11
    12
    13
    14
    15

    Erratum.

    Published in:
    2010
    Publication type:
    Correction Notice